By G HossainPosted on May 20, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year. Parabilis follows hefty Regeneron deal with IPO push Post navigation FDA’s absent leaders, the millions pharma CEOs make, and pancreatic cancer’s momentumModerna’s stock rides hantavirus fears as spotlight returns to infectious disease platform